The President & CEO of Catalyst Biosciences Inc (NASDAQ: CBIO) is Buying Shares

By George MacDonald

Today, the President & CEO of Catalyst Biosciences Inc (NASDAQ: CBIO), USMAN NASSIM, bought shares of CBIO for $8,000.

USMAN NASSIM increased his holding by 2.96% to a total of $2.44. In addition to USMAN NASSIM, 2 other CBIO executives reported Buy trades in the last month.

Based on Catalyst Biosciences Inc`s latest earnings report from September 30, the company posted quarterly revenue of $109k and GAAP net loss of $5.05M. In comparison, last year the company earned revenue of $25k and had a GAAP net loss of $4.86M. The company has a one year high of $21.60 and a one year low of $1.89. Currently, Catalyst Biosciences Inc has an average volume of 390.3k.

Looking at blogger coverage of CBIO, there is a 100% Bullish tendency on the stock, in relation to an 80% average bullish tendency within the Healthcare sector.

Over the last 3 months, the insider sentiment on Catalyst Biosciences Inc has been neutral based on 11 corporate insider transactions. This sentiment is higher than the average sector sentiment of insiders.

Catalyst Biosciences Inc is a clinical-stage biopharmaceutical company. The Company is focused on creating and developing novel medicines to address serious medical conditions.